# Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain

> **NCT00195377** · — · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 1000 (—)

## Conditions studied

- Arthritis, Psoriatic
- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT00195377
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 1000 (—)
- **Last updated:** 2009-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195377, "Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00195377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*